Fifty-three adults who had received SCT as children responded to questionnaires on health-related quality of life (HRQoL) (Swedish HRQoL survey (SWED-QUAL)), sense of coherence (SOC), anxiety and depression (HAD) and a health and symptom inventory. Late effects were classified following the Common Terminology Criteria for Adverse Events (CTCAE) v. 3.0. HRQoL was below norm in 9 of 13 SWED-QUAL domains. Poorest domains (Po0.001) were satisfaction with physical health, general health, partner relations and sexual function, whereas emotional wellbeing and satisfaction with family life were on par with the norm. Older age, time elapsed post-SCT and fewer self-reported symptoms correlated with better HRQoL. Unfavourable late effect scores had no or limited impact, whereas age at SCT or TBI did not adversely affect HRQoL. Most subjects were well subjectively and objectively, whereas 24% had more complicated late effects. The median Karnofsky score was 90, 13% of subjects having scores below 80. In total, 53% reported pain, whereas 42.5% had memory and concentration problems. Anxiety and/or depression, reported by 35%, were associated with lower HRQoL and SOC ratings. Overall, 55% reported infertility and expressed difficulty with this. To conclude, childhood SCT did not negatively affect overall health for most of these adult long-term survivors, although poorer HRQoL with psychological and cognitive problems are common.
Introduction
The successful development of SCT and an increased availability of alternative donor sources mean that more long-term survivors today have the opportunity to live relatively normal lives. 1, 2 However, SCT remains a highrisk treatment with serious late effects. 3, 4 This means that children require continued follow-up into adulthood, and a general recommendation is that we should also examine the health-related quality of life (HRQoL) and life situations for this growing group. 5, 6 Many patients achieve a relatively good QoL after SCT. [7] [8] [9] These studies have primarily been performed in adults, although a few recent studies concerned children. [10] [11] [12] [13] Our results in children indicated that a majority experience good HRQoL in many areas. 10 We still, however, have very limited systematic knowledge about the life situation for these children once they grow up, as few studies focus on adults who had undergone SCT in childhood. 14, 15 This study examines the health status, the HRQoL and late effects and how they may interact in adult long-term survivors after SCT in childhood.
Patients and methods
Patients surviving for at least 5 years (n ¼ 73; age, range 19-42 years, mean ¼ 26 years) having undergone SCT as children (age at SCT, range 1-16 years; median ¼ 10 years) between 1978 and 2001 at the Karolinska University Hospital, Huddinge, Sweden, and who had transferred from the Children's Department to the adult haematology service, were asked regarding participation. Out of these 73 patients, 10 were lost to follow-up or were living abroad, 6 persons declined to take part in the study, whereas 4 did not complete the study questionnaire. Two patients with severe neurodegenerative disorders that were manifest before SCT were not included in the study. All included patients were followed up at a dedicated post-SCT clinic. Medical records were updated at least every year and not less than every second year for those more than 10 years post-SCT. A total of 53 persons took part (73%) and received a questionnaire that was completed and returned to the centre. In total, 55% of the study group underwent SCT during [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] and 45% were transplanted during 1991-2001. Table 1 shows characteristics of study participants and non-participants, who were comparable in terms of gender, age at time of study, age at SCT, malignant or non-malignant diagnosis and number of years after treatment. Approval for this study was obtained from the Human Research Ethics Committee at Karolinska Institutet.
Assessment of health and disability
Late effects score and secondary malignancies. A physician blinded to the outcome of the HRQoL studies reviewed each patient's medical records and assessed any reported late effects in 12 problem categories, as presented in Table 2 , on a scale of 0 (no symptoms) to 4 (debilitating or life-threatening disease) following the classification of the NCI Common Terminology Criteria for Adverse Events (CTCAE) v. 3.0. 16 Problem categories that appreciably affected daily life were included. Infertility, a history of cataracts, cardiac, endocrine or psychiatric problems were not included here as they were adequately controlled Table 1 Characteristics of participating and non-participating survivors after SCT during childhood b An individual total late effects score was calculated as the sum of the 12 category scores. The number (n) and percentage of SCT adults (%) at each of five total score levels are described, where a total score of 4-10 represents either several or more severe/complicated sequelae. Growth impairment has a maximum score of 2. Score 1 ¼ stature pÀ2 s.d., according to norm. by treatment or nonexistent or were not fully ascertainable from patient records (infertility). None of the patients had clinical cardiac problems. Only two patients (one dropout) had suffered from overt psychiatric disorders. The hospital anxiety and depression (HAD) scale was used to detect clinically significant depression. A total late effects score was calculated for each patient as the sum of the category scores, as published earlier. 10 Subjective health and symptom inventory checklist. A selfassessment checklist used in our earlier published report in SCT children 10 was adapted to the adult population with 22 items subdivided into four scales (symptom frequency/ symptom severity/pain/cognition). Patients were requested to grade the severity and/or frequency of symptoms or problems on a scale of 0-3 (0 ¼ always, 1 ¼ often, 2 ¼ sometimes and 3 ¼ not at all). The pain scale score indicates 0 ¼ always, 1 ¼ almost every day, 2 ¼ almost every week and 3 ¼ not at all, with higher scale scores indicating better health.
The mean score for the items in each scale was calculated. The pain scale included items relating to pain levels, whereas the subjective symptom scale included items relating to GVHD and late effects, such as dryness of skin, mucous membranes and eyes; alopecia; nausea; gastrointestinal problems; sleep disturbances, and so on. The cognition scale concerned concentration and memory problems. The Cronbach's alpha coefficient for the scales ranged from 0.70 to 0.92.
Karnofsky scale. The Karnofsky performance scale measures the level of activity and medical care requirements. The scale ranges from 10 (moribund) to 100 (normal function). 17 Instruments for HRQoL assessment SWED-QUAL. The Swedish HRQoL profile (SWED-QUAL) was used to collect the data. 18 The patient was asked to reflect on the weeks immediately prior to the questionnaire. SWED-QUAL consists of 68 items with answer alternatives on a Likert scale that uses 11 multi-item and 2 single-item scales that concern different aspects or areas of HRQoL (Table 3) .
A higher score indicates a better QoL. SWED-QUAL is a validated instrument 18, 19 and has been used in similar Swedish studies 19 and in studies on other illness-related groups. 19, 20 For comparison, data from a large Swedish national SWED-QUAL reference group of adults (n ¼ 2500, age 17-84 years) collected in 1998 was used. From this group, an age-matched random sample consisting of 357 individuals (age 19-42 years, mean ¼ 27 years) was extracted for statistical comparison using analysis of variance (B Brorsson, personal communication; Wandell et al.
19
). The Cronbach's alpha coefficient of the multi-item scales ranged from 0.78 to 0.97. Questions on self-image (two items), infertility (three items), sexuality (one item) and whether the subjects had received information and advice on sexual matters were added to the questionnaire.
Sense of coherence Sense of coherence-13: Antonovsky 21 introduced 'sense of coherence' (SOC), a measure of a global tendency to view life situations as comprehensible, manageable and meaningful. Here, we used SOC-13, a shortened variant that has proved reliable. 22 In this study, the Cronbach's alpha coefficient was 0.91.
Assessment of anxiety and depression HAD. HAD is a self-assessment scale for detecting depression and anxiety in patients. 23 It is also a reliable and valid instrument for measuring the severity of an emotional disorder. 23, 24 HAD consists of 14 items each with 4 answer alternatives: 0 (no problems) to 3 (very severe problems). It has two subscales, one for anxiety (seven items) and one for depression (seven items). A score sum of 8-10 indicates possible clinical problems, and greater than 11 suggests a clear clinical case. [23] [24] [25] In the current study, the Cronbach's alpha coefficient was 0.85 for the anxiety scale and 0.87 for the depression scale.
Statistical analysis
The data were analysed using SPSS version 14.0 for Windows. Descriptive statistics, Student's t-test and the non-parametric Mann-Whitney U-test were used to assess the effects of age, diagnosis, donor, treatment and subjective or objective health on HRQoL domains in the SWED-QUAL and HAD scales. One-way analysis of variance was performed to explore differences between the SCT group and a comparison group. The Pearson Mean, standard deviation and range of the SCT group of adults (n ¼ 53) as compared with average stature and weight (mean) of men and women in Sweden. 25 product moment correlation coefficient was used to assess construct validity by correlating SWED-QUAL and SOC-13 with HAD. Inter-correlation between health variables and the HRQL instrument and SOC and HAD were also examined. These calculations were and should be interpreted with caution and the results are seen as hypotheses rather than confirmatory as multiple comparisons, in a limited population, increase the risk of obtaining significant results by chance. To make the conclusions more reliable, we avoided lending too much weight to single significant differences. Significance at Po0.05 is assumed throughout.
Results

Health factors
Late effects and neoplastic disorders. The late effect scores (according to CTCAE v. 3.0) and the total late effect scores are presented in Tables 2a and b . The most frequently recorded problems, after short stature, were impaired pulmonary function, skeletal pain and appearance. The mean heights and weights were below the normal population means 26 (Table 3 ). Recent chronic GVHD was mentioned in only one case, a patient who was 5 years post-SCT and whose medication had successfully been discontinued 1 year earlier. Three patients had developed neoplasia, all were at least 10 years after SCT and had been exposed to TBI. Two of these patients had developed cavernomas, one of them in combination with meningeoma. Another patient, originally treated for myelodysplastic syndrome had a recurrence of the original malignant clone, presenting as a vertebral chloroma 11 years after SCT. One of the dropouts, a woman, developed bilateral and disseminated breast cancer more than 20 years post-SCT.
Subjective health and symptom inventory checklist. Figure 1 illustrates the 'symptom frequency scale' and 'symptom severity scale' used here. A difference (Po0.05 by paired sample t-test) existed between how frequently symptoms were experienced by the patient and the self-rated severity of these symptoms. The results indicate that patients experience physical symptoms frequently but rate only no or mild discomfort because of them.
On the 'cognition scale' (Figure 1 ), 42.5% of patients rated that they have concentration and memory problems 'occasionally' to 'often'. On the 'pain scale', 53% rated that they have problems with pain 'weekly' to 'always' (Figure 1) . The most frequently reported symptoms, other than pain and cognition problems are listed in Table 4 .
Most frequently reported pain areas were neck and shoulders (39%), back (30%), knees (19%) and hips (19%). In total, 7% reported that they use analgesics daily, 38% only occasionally and 55% never use analgesics. Overall, 14 respondents exercised more than twice weekly, 17 exercised 1-4 times per month, whereas 9 persons admitted that they never exercised.
Karnofsky score. Karnofsky scores ranged from 50 to 100 (median 90); 13% of the subjects (n ¼ 6) had scores below 80.
HRQoL SWED-QUAL. This group had an HRQoL below norm (Po0.01) in 9 of 13 SWED-QUAL domains. These areas were satisfaction with physical health, general health, pain, cognitive function, role limitations due to physical and emotional health, partner relations and sexual function. Four domains, emotional wellbeing (positive and negative affect), sleep function and satisfaction with family life were on par with the norm (Table 5) . By calculating clinically relevant effect size as differences in mean effect size between the comparative populations by the s.d. for the comparison group, the largest clinically relevant effects are found for sexual function, partner relations and general health perception (results not presented).
Sense of coherence SOC-13. The SOC-13 scores in the SCT group (n ¼ 49, mean ¼ 69.6, s.d. ¼ 15.6, score range 33-89) were on par with that of the normative population (n ¼ 236, mean ¼ 67.6, s.d. ¼ 10.0). 25 
HAD
In total, 35% (n ¼ 18) of HAD respondents (n ¼ 51) reported serious problems (HAD score X8) with anxiety and depression. Seven respondents had serious problems with both anxiety and depression, eight with anxiety only and three with depression only. In comparison, anxiety and/or depression problems were reported by 25% of a comparison group of oncology outpatients (n ¼ 73), and by 10% of a normative population (n ¼ 152). 24 The 18 respondents with anxiety/depression (HAD scores X8) rated poorer scores on SWED-QUAL scales (Figure 2a ) (except on scales on satisfaction regarding relationship with spouse/relationship with family/sexual function) than the rest of the SCT group (Po0.01-0.05), as well as on all scales in the subjective symptom checklist, and SOC-13. 
Self-image
In total, 49% of the adult SCT group indicated that they consider themselves attractive, 41% not particularly attractive and 10% not at all attractive. Overall, 19% of the SCT group felt that those around them considered them less attractive because of their treatment and illness, whereas the remaining respondents (81%) did not consider this to be of significance.
The relationship between objective health (late effects) and HRQoL, HAD and SOC-13
The total late effects score correlated negatively with 4 of 13 SWED-QUAL scales; specifically general health (r ¼ À0.39, Po0.01), physical health (r ¼ À0.37, Po0.01), emotional wellbeing, positive affect (r ¼ À0.34, Po0.05) and satisfaction with physical ability (r ¼ À0.37, Po0.01). No correlation was found between the total late effects score and HAD and SOC-13 scores.
The relationship between self-rated symptoms and HRQoL Most areas in SWED-QUAL (10 of 13 scales), with the exception of the areas 'satisfaction with family life', 'relationship to spouse' and 'sexual function and satisfaction', correlated positively with high (favourable) self-rated scores in the symptoms frequency and severity scales of the subjective symptom inventory checklist (Po0.01) (Figure 2b ).
Gender, age and diagnosis vs HRQoL and health Gender. No difference was found between genders in HRQoL, HAD, SOC-13, total late effects score or self-rated subjective health. The frequency of self-rated symptoms, except pain and cognition problems (see Figure 1) , that occur most frequently in the SCT group, are shown as a percentage of the total study group (n ¼ 53). Abbreviations: ANOVA ¼ analysis of variance; HRQoL ¼ health-related quality of life. SWED-QUAL: each scale is represented as a 0-100 index. A higher score indicates better HRQoL. Data are given as mean ± s.d. One-way between-groups ANOVA was performed on the SCT sample and an age-matched normal sample (Patients and methods and Wandell et al.
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). Significance at Po0.05 is assumed throughout.
Po0.05) and depression scales (r ¼ À0.28, Po0.05) and likewise a (favourable) correlation with the self-rated symptom score. Time post-SCT did not correlate with the total late effects score. Age at SCT did not correlate with SWED-QUAL scores, whereas there was a negative correlation with the total late effects score (r ¼ À0.32, Po0.05).
Diagnosis. The patient's original diagnosis (leukaemia or non-malignant disease) did not significantly affect the scoring of any of the SWED-QUAL scales. In the subjective health and symptom inventory checklist, the non-malignant group showed a trend towards a worse cognitive function (P ¼ 0.057) as compared with the leukaemia group. TBI, donor, HRQoL and subjective/objective health Whether the patient had been exposed to TBI (at the time, in most cases single fraction 10 Gy), or not, had no effect on the SWED-QUAL subscale ratings, with the exception of a negative trend (non-favourable) in the cognition scale (P ¼ 0.07). Neither was there an impact on the total late effects score (apart from one patient in the TBI group who had a very high total late effects score of 10). The non-TBI group reported more pain in the symptom inventory checklist.
There was no difference in the health variables between patients who had a related or unrelated donor.
Infertility and advice in sexual matters
Out of 49 respondents who answered questions on infertility, 24 reported that they believed they were infertile, 6 were fertile and 19 did not know. Four subjects, 2 men and 2 women, had altogether six biological children. Eight persons had investigated or considered alternatives such as adoption; the remainder reported that they had not investigated alternatives, or did not know. Of the 28 persons who answered the question 'Does being infertile trouble you?' 85% reported that they were 'somewhat' to 'very' troubled.
In total, 62% (n ¼ 31) had not received advice in sexual matters, whereas the remaining patients (n ¼ 19) reported that they had. Those who requested more discussions and information regarding sexual issues preferred that the initiative for such discussions would come from healthcare professionals (n ¼ 11), themselves (n ¼ 6) or through other information such as brochures (n ¼ 1).
Discussion
In some contrast to other studies performed in post-SCT adults, 9, 14, 15 the subjects in this study experience a HRQoL that is poorer than age-matched norm within several domains, particularly related to physical health, whereas emotional wellbeing domains are on par with norm (Table 5 ). Yet a majority of the patients rated their own health as good in the subjective symptom inventory (Figure 1 ). This is also supported by, overall, high Karnofsky functional scores and the finding that not more than 24% of the study group was afflicted by more complicated and severe late effects (Table 2b ). The limited study group size and the choice of control population (which was assembled 7 years before the study group) may in part explain why the HRQoL outcome is at variance with other studies. However, the rather long (median ¼ 16 years), continuous and close follow-up of this group lend plausibility to these results, which are not at odds with our clinical experience.
We noted in our study in children, who were at least 3 years after SCT, that parent-rated HRQoL correlated negatively with objective late effects, whereas children themselves experienced the strongest association between self-rated symptoms and HRQoL. 10, 27 Interestingly, adults in the current study also reported a stronger association between self-rated symptoms and HRQoL, and to lesser extent between HRQoL and late effects. Although these physician-rated physical difficulties indicated a poorer HRQoL within the areas of physical function, emotional wellbeing and satisfaction with close relationships, selfrated difficulties indicated an association with poorer HRQoL in most areas. This supports the notion that the subjective perception of health is of specific importance to HRQoL. 15 Many patients indicated that they often experienced problems with pain, dry skin, fatigue, and so on, yet they reported that these symptoms had limited impact on HRQoL and self-rated symptom severity scoring.
Another important finding is that a large proportion of the group reported problems with their memory and capacity for concentration (Figure 1 ). These problems were not always sufficiently documented in the medical records (Table 2a) . This is an important omission as cognitive problems may impact considerably on a young person in terms of establishing himself or herself as an adult. 1, 12, 28 This also emphasizes the importance of patient-reported outcomes for follow-up care. 29 The SCT group rated a poorer HRQoL within the sexuality area when compared with a normative population, as observed in other studies. 9, 30 One finding to consider is that many patients did not feel that they had received advice in sexual matters, indicating a need for research and clinical support regarding sexuality and fertility issues after SCT.
9,31 Self-image and physical appearance that are affected after treatment have been shown to lead to poorer wellbeing and more anxiety among adult survivors. 32 Men in particular, in this study, are well below the general population both in height and weight (Table 3) . Pendley et al. 33 found that young persons with longer post-cancer treatment times reported a more negative body image, and problems can arise long after treatment has ended. 32, 34 Most adults in our study group, however, had a predominantly positive self-image.
A good SOC can act as a buffer for the physical and psychological distress that illness and treatment can cause in daily life. 22 We did not find clear-cut impact of many late effects or self-rated symptoms on SOC. A separate ocular inspection of the data of individuals with many objective symptoms and subjective problems gave an inconsistently broad range of values: persons with many late effects may have a low as well as a strong SOC. Importantly, incidence of anxiety and/or depression among SCT adults (35%) was higher than in a normative population. 24 Clinical levels of anxiety and/or depression (HAD) were associated with low or very low SOC and a poorer QoL in most HRQoL areas. However, late effects were not a major issue among these persons. A cause of increasing levels of psychological problems in the general population, particularly among young women, is believed to be the delayed entry into adulthood of the past decades, in terms of employment and starting a family. 35 Whether this also contributes to psychological problems among these patients is outside the scope of this study, but it is an important area to investigate further.
The subpar HRQoL in several SWED-QUAL domains indicates that these adults need more support in a longterm perspective. A clinical conclusion might be to focus more resources on clinical support in the transition between youth to adulthood, and help the former SCT patient to cope with sexuality/fertility issues and psychological problems such as anxiety and depression. More importantly, cognitive problems need to be documented thoroughly to gain knowledge and be able to support long-term survivors in the future. In keeping with other studies, our results show that SCT in childhood and youth can impact on later life, and indicates a need for increased long-lasting support. Thus, to optimally support the post-SCT patient, it is essential to consider not only medical but also social, emotional and psychological aspects during follow-up.
